
A comprehensive examination of what we know as fact about fenbendazole and cancer, including medical papers and evidence, practical realities, financial costs, and unknowns. Educational resources only. Always consult a licensed oncologist
| Platform | Pricing | Only free issues | Publishes | Daily | |
|---|---|---|---|---|---|
| Issues | 168 | Founded | 4 months ago | Last Issue | 6 days ago |
| Active | |||||

Treatment for prostate cancer spans conventional standard-of-care modalities as well as emerging investigational and repurposed therapeutic strategies aimed at overcoming drug resistance.
Data from the global cancer observational databases (GLOBOCAN 2020/2022) demonstrate that the global oncological burden reached approximately 20 million new cancer diagnoses and nearly...
What if an inexpensive, decades-old antiparasitic tablet sitting in neighborhood pharmacies holds the key to dismantling multi-drug resistance in aggressive, late-stage cancers? While conventional oncology spends billions d...
Dr. William Makis MD. Radiologist, Oncologist, Cancer Researcher, Author of 100+ publications. Top Substack Author.
Makis Health Substack
Yes, mebendazole (MBZ) can be combined with standard chemotherapy drugs, targeted therapies, hormone treatments, and radiotherapy. In fact, preclinical and clinical literature demonstrates that MBZ frequently acts as a synergistic sensitize...
Subscribers, engagement, traffic and sponsorship for Fenbendazole & Cancer.
| Subscribers | Engagement | 80 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
How this newsletter ranks in the official Substack charts.
| #75 | |
| #185 |
The writers behind this newsletter.
A comprehensive examination of what we actually know about Fenbendazole and cancer, including the science, the evidence, the practical realities, and the unknowns. Everything here is for education and information only, not medical advice.
You can find recent issues that have been published by Fenbendazole & Cancer on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to Fenbendazole & Cancer, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch Fenbendazole & Cancer as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Fenbendazole & Cancer using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like Fenbendazole & Cancer. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.